Healthcare -
Biotechnology - NASDAQ - US
$ 6.47
-0.919 %
$ 277 M
Market Cap
-11.55
P/E
DMAC - TOTAL RECEIVABLES
Total Receivables DMAC - DiaMedica Therapeutics Inc.
369 K
LAST VALUE
68.48%
2 YEAR CAGR
-13.90%
5 YEAR CAGR
0.00%
10 YEAR CAGR